DELTICOM-AG
26.11.2015 11:47:38 CET | Business Wire | Press release
It’s buzzing on our roads and motorways. In the first nine months of 2015, there were almost 18% more trucks and commercial vehicles registered in the UK than last year.* In light of these figures, it is worth doing some forward planning and invest wisely. In the UK, the number of road traffic accidents leading to personal injury involving goods vehicles rose in 2014 by 6% in comparison to the previous year.** New tyres can make an absolutely critical contribution to safe mobility.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151126005106/en/
That’s why safety experts advise transport companies and business people who run a small fleet to service their vehicles intensively. Not only does this contribute to increased working life, it also makes an important contribution to road safety. During long, dark European winters with constantly changing weather conditions, having perfect grip increases the mobility of goods transporters and businesses by a significant multiple. “It’s worth investing in fresh tyres , not only when they’re worn, or you have to change because of the season. Very often, every millimetre counts, such as in tricky traffic situations. With new tyres , both driver and business owner are well equipped. Over the last few years, we have specialised in supplying a wide range of complete winter tyres size 17.5”, as these tyres, in particular, cover the whole spectrum of small fleet operators. Business people can count on our online car tyre shops , with excellent availability of 17.5” tyres in all price/performance categories” , says Andreas Wilmsmeier, Key-Account Manager Truck and Commercial Tyres EU at Delticom . He continues: “Our customers benefit from a wide variety of high-quality tyres. More and more transport experts are on the road in the best possible way with our own brand Goodride. Goodride truck tyres are characterised by a high level of reliability and economy”.
At the Delticom online stores for dealers and garages attractive packages are offered to all kind of businesses, no matter if small or large. With a winter discount promotion in December the online tyre dealer supports the safety of its customers. For each purchased truck tyre 10 euro discount will be granted per at the online shops for professional customers in Germany , Austria , Switzerland , France , Italy , Spain and the Netherlands (in Switzerland 10 CHF). The winter discount promotion starts at 1st of December and ends on the 31st of December 2015.
Buying tyres online provide numerous benefits: the stores are “open all hours” - 365 days a year, 24/7, thus saving that valuable resource - time. In addition, business owners can increase efficiency by benefitting from low-cost deals all year round. The truck / commercial vehicle team at Delticom can also offer personal advice if required. Within the UK, the tyres are generally dispatched in 2 - 4 days.
* Source: www.smmt.co.uk
** Source: www.gov.uk
Tyres for trucks, light trucks and commercial vehicles you can find in the online shops for:
- Dealers: www.yourtyres.co.uk , www.autoreifenonline.de , www.autoreifenonline.at , www.autoreifenonline.ch , www.pneus-auto.fr , www.pneumatici123.it , www.neumaticos123.com , www.porbanden.nl
- Fleet clients: www.fleettyres24.co.uk , www.flotten24.de , www.flotten24.at , www.flotten24.ch , www.flotte24.fr , www.flotta24.it , www.fleet24.nl
Truck tyres also available at the online shops for consumers : www.mytyres.co.uk/Truck-Tyres , www.reifendirekt.de , www.reifendirekt.at , www.reifendirekt.ch/LKW-Reifen.html , www.123pneus.fr/pneus_camion , www.gommadiretto.it/Pneumatici_autocarri , www.neumaticos-online.es/Neumaticos_camiones , www.autobandenmarkt.nl/Vrachtwagenbanden
Tyre tests: www.tyretests.com
Information about the company: www.delti.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20151126005106/en/
Contact:
Delticom AG
Susanne Kindor-d’Unienville
T: +49 511 93634852
E-Mail:
susanne.kindor@delti.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom